Stored Autologous Blood Transfusion Market 2025-2033 - Driven by Preoperative Donation | North America Dominates | Top Companies are Medtronic, JMS Co. Ltd., Narang Medical Limited., Becton.

Stored Autologous Blood Transfusion Market Size and Forecast

DataM Intelligence has published a new research report on "Stored Autologous Blood Transfusion Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Exclusive Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/stored-autologous-blood-transfusion-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Recent Developments:
✅ October 2025: A leading blood management solutions provider introduced an advanced automated autologous blood storage system with extended shelf-life optimization. The system integrates temperature-controlled storage and digital tracking to improve safety, reduce wastage, and enhance perioperative blood availability for elective surgeries.

✅ August 2025: Hospitals across North America and Europe increased adoption of preoperative autologous blood donation (PABD) programs, driven by rising concerns over transfusion-transmitted infections and growing patient preference for personalized blood management strategies in orthopedic and cardiac surgeries.

✅ June 2025: A biotech firm launched a closed-loop autologous blood processing and storage platform, enabling seamless collection, labeling, storage, and reinfusion. The solution enhances compliance with transfusion safety standards and supports patient blood management (PBM) protocols.

✅ April 2025: Regulatory authorities in several Asian countries updated clinical guidelines promoting stored autologous blood transfusion as a risk-mitigation strategy in elective procedures, encouraging hospitals to reduce dependency on allogeneic blood supplies amid fluctuating donor availability.

Mergers & Acquisitions:
✅ November 2025: A global medical device company acquired a specialty blood storage and transfusion technology firm to expand its autologous transfusion product portfolio and strengthen its position in perioperative blood management solutions.

✅ September 2025: A major healthcare services provider acquired a hospital-based blood banking software company, enhancing digital tracking, traceability, and inventory management capabilities for stored autologous blood transfusion programs.

✅ July 2025: A multinational diagnostics and laboratory equipment manufacturer completed the acquisition of a blood processing consumables business, enabling integrated offerings for autologous blood collection, storage, and reinfusion workflows.

✅ May 2025: A patient blood management solutions company acquired a clinical analytics startup, allowing real-time monitoring of autologous blood utilization, wastage reduction, and outcome optimization across surgical departments.

Key Players:

Terumo Corporation, Haemonetics Corporation, Medtronic, JMS Co. Ltd., Narang Medical Limited., Becton, Dickinson and Company, Fresenius Kabi AG, Nipro, Macopharma and Cardinal Health.

Growth Forecast Projected:

The Global Stored Autologous Blood Transfusion Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Stored Autologous Blood Transfusion Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=stored-autologous-blood-transfusion-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

Key Segments:

By Product Type
The market is segmented into Blood Collection Devices 35%, Blood Storage Devices 25%, Blood Transfusion Kits 22%, and Blood Processing Products 18%, with blood collection devices dominating due to their essential role in preoperative autologous blood collection. Blood storage devices hold a significant share driven by the need for safe and temperature-controlled storage. Blood transfusion kits are widely used during surgical procedures, while blood processing products support separation, filtration, and quality maintenance of stored blood.

By Application
By application, the market includes Orthopedic Surgeries 40%, General Surgeries 30%, Obstetrics & Gynecology Surgeries 20%, and Others 10%, with orthopedic surgeries dominating due to high blood loss associated with joint replacements and spinal procedures. General surgeries show strong demand for autologous transfusion to reduce transfusion-related risks. Obstetrics & gynecology surgeries increasingly adopt stored autologous blood to enhance maternal safety. Other applications include cardiovascular and trauma surgeries.

By Storage Duration
Based on storage duration, the market is segmented into Short-Term Storage 65% and Long-Term Storage 35%, with short-term storage dominating due to the widespread use of autologous blood collected shortly before scheduled surgeries. Long-term storage is gaining traction with improvements in blood preservation technologies and cryopreservation methods, supporting elective and complex procedures.

By Technology
By technology, the market is segmented into Manual Blood Collection 55% and Automated Blood Collection 45%, with manual blood collection holding a slightly higher share due to lower cost and widespread availability across healthcare facilities. Automated blood collection is rapidly growing owing to higher efficiency, reduced contamination risk, and improved patient safety. Technological advancements support the shift toward automation.

By End User
By end-user, the market includes Hospitals 60%, Blood Banks 20%, Ambulatory Surgical Centers 15%, and Others 5%, with hospitals dominating due to high surgical volumes, availability of transfusion infrastructure, and integrated blood management programs. Blood banks play a critical role in storage and processing. Ambulatory surgical centers are increasingly adopting autologous transfusion for planned procedures. Other end-users include specialty clinics and research centers.

Regional Analysis
North America - 35% Share
North America leads with 35% share driven by advanced surgical practices, strong patient blood management programs, and high awareness of transfusion safety in the U.S. and Canada. Orthopedic and general surgeries dominate demand. Hospitals are the primary end-users. Favorable reimbursement policies support market growth.

Europe - 25% Share
Europe accounts for 25% share, supported by strong healthcare infrastructure, increasing elective surgeries, and stringent blood safety regulations across Germany, France, and the UK. Short-term storage and automated blood collection technologies are widely adopted. Hospitals and blood banks drive demand.

Asia Pacific - 30% Share
Asia Pacific holds 30% share due to rising surgical volumes, expanding hospital infrastructure, and growing awareness of autologous transfusion benefits in China, India, Japan, and South Korea. Orthopedic and obstetric surgeries dominate. Increasing healthcare investments support rapid market growth.

Latin America - 5% Share
Latin America captures 5% share, driven by improving surgical facilities and increasing adoption of blood management practices in Brazil and Mexico. Hospitals remain the key end-users. Growing awareness supports gradual market expansion.

Middle East & Africa - 5% Share
The Middle East & Africa region holds 5% share, supported by healthcare infrastructure development, rising surgical procedures, and growing focus on transfusion safety in UAE, Saudi Arabia, and South Africa. Hospital-based autologous transfusion programs drive regional demand.

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/stored-autologous-blood-transfusion-market?rk

(Single User Report: USD 4350 & One Year Database Subscription: USD 12K)

FAQ

Q1: What is the current size of the Stored Autologous Blood Transfusion Market?

A: Stored Autologous Blood Transfusion Market reached US$149.8 billion in 2024 and is expected to reach US$182.3 billion by 2033.

Q2: How rapidly will the Market expand?

A: The Stored Autologous Blood Transfusion market is projected to grow at a CAGR of 2.5 % between 2025 and 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.